Skip to main
MMNFF

MMNFF Market Capitalization Overview

Market Cap: $200.00 as of Feb 20, 2026

$200.00
As of Feb 20, 2026, MMNFF has a market capitalization of $200.00. Over the past 30 days, its market cap has decreased by -85.71%, while in the last 12 months, it has decreased by -85.71%.

Market capitalization represents the total value of MedMen Enterprises Inc. as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

MMNFF Market Cap Formula = Stock Price * Shares Outstanding

The market cap of MMNFF helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MMNFF Market Cap History

DateMarket CapChange

MMNFF End of Year Market Cap History

DateMarket CapChange
2026$200.00-85.71%
2024$1.40K-99.99%
2023$19.19M+1.66%
2022$18.88M-79.06%
2021$90.15M

FAQs About MedMen Enterprises Inc. (MMNFF) Market Cap

As of Feb 20, 2026, the market capitalization of MMNFF is $200.00. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, MedMen Enterprises Inc.’s market capitalization has increased by —, changing from – to $200.00 as of Feb 20, 2026.

In the last 3 months, MedMen Enterprises Inc.’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, MedMen Enterprises Inc.’s market capitalization decreased from $19.19M in January to $1.40K in December, reflecting a -99.99% change.

In the past five years, MMNFF has had a compound annual growth rate (CAGR) of -93.72% in market capitalization. This means its market cap has shrunk at an average rate of -93.72% per year.

MedMen Enterprises Inc. (MMNFF)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.